Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Slavik

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Immunologic Research|June 22, 1999
CD28/CTLA-4 and CD80/CD86 families: signaling and functionJ M Slavik, J E Hutchcroft, B E Bierer
Cancer Treatment Reports|September 1, 1982
Phase II clinical study of Yoshi 864 in epithelial ovarian carcinoma: A Gynecologic Oncology Group StudyM Slavik, H Muss, J A Blessing, et al.
Journal of Nutritional Science and Vitaminology|October 1, 1983
6-azauridine triacetate induced hyper beta-alaninemia and its decrease by administration of pyridoxineM Slavik, O Blanc, K J Smith, et al.
Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology|November 22, 1971
Hyperaminoacidemia in rabbits treated with 6-azauridine triacetateM Slavik, H R Keiser, W Lovenberg, et al.
Vestnik Rentgenologii I Radiologii|May 1, 1980
[Primary tumors of the spine]J Kolar, N Zidková, Z Matejevský, et al.
Medical and Pediatric Oncology|January 1, 1976
Overview of early and investigational chemotherapeutic agents in solid tumorsM Rozencweig, M Slavik, F M Muggia, et al.
FEBS Letters|October 15, 1974
The incorporation of L-(14C) fucose into glycoprotein fractions of liver plasma membranesJ R Riordan, M Mitranic, M Slavik, et al.
American Journal of Clinical Oncology|October 1, 1982
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and ExperienceM Slavik, J C Arsenau, J Blessing, et al.
Cancer Clinical Trials|January 1, 1980
Phase I clinical studies with WR-2721M M Kligerman, M T Shaw, M Slavik, et al.
Experimental Cell Research|March 15, 1973
Androgen-stimulated labelling of chromosomal proteins by isolated prostate nucleiK M Anderson, M Slavik, A K Evans, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Immunologic Research|June 22, 1999
CD28/CTLA-4 and CD80/CD86 families: signaling and functionJ M Slavik, J E Hutchcroft, B E Bierer
Cancer Treatment Reports|September 1, 1982
Phase II clinical study of Yoshi 864 in epithelial ovarian carcinoma: A Gynecologic Oncology Group StudyM Slavik, H Muss, J A Blessing, et al.
Journal of Nutritional Science and Vitaminology|October 1, 1983
6-azauridine triacetate induced hyper beta-alaninemia and its decrease by administration of pyridoxineM Slavik, O Blanc, K J Smith, et al.
Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology|November 22, 1971
Hyperaminoacidemia in rabbits treated with 6-azauridine triacetateM Slavik, H R Keiser, W Lovenberg, et al.
Vestnik Rentgenologii I Radiologii|May 1, 1980
[Primary tumors of the spine]J Kolar, N Zidková, Z Matejevský, et al.
Medical and Pediatric Oncology|January 1, 1976
Overview of early and investigational chemotherapeutic agents in solid tumorsM Rozencweig, M Slavik, F M Muggia, et al.
FEBS Letters|October 15, 1974
The incorporation of L-(14C) fucose into glycoprotein fractions of liver plasma membranesJ R Riordan, M Mitranic, M Slavik, et al.
American Journal of Clinical Oncology|October 1, 1982
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and ExperienceM Slavik, J C Arsenau, J Blessing, et al.
Cancer Clinical Trials|January 1, 1980
Phase I clinical studies with WR-2721M M Kligerman, M T Shaw, M Slavik, et al.
Experimental Cell Research|March 15, 1973
Androgen-stimulated labelling of chromosomal proteins by isolated prostate nucleiK M Anderson, M Slavik, A K Evans, et al.
Pageof 14